col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


170 Results       Page 1

 [1] 
Elsevier: Biomedicine & Pharmacotherapy
  original article Date Title Authors   All Authors
1 [GO] 2023―Mar―10 Ovatodiolide inhibits SARS-CoV-2 replication and ameliorates pulmonary fibrosis through suppression of the TGF-β/TβRs signaling pathway Wei-Chung Chiou, Guan-Jhong Huang, Tein-Yao Chang, Tzu-Lan Hsia, Hao-You Yu, Jir-Mehng Lo, et al. (+2)
2 [GO] 2023―Feb―06 Paxlovid (Nirmatrelvir/Ritonavir): A new approach to Covid-19 therapy? Seyed Mohammad Reza Hashemian, Amirhossein Sheida, Mohammad Taghizadieh, Mohammad Yousef Memar, Michael R Hamblin, Hossein Bannazadeh Baghi, et al. (+3)
3 [GO] 2023―Jan―23 Bmal1 and Gut-lung axis in SARS-CoV-2 infection: new insight into the effects of melatonin on COVID-19 patients? Mohammad Rafi Khezri, Reza Varzandeh, Morteza Ghasemnejad-Berenji
4 [GO] 2023―Jan―16 Computer-aided drug design for the Pain-Like protease (PLpro) inhibitors against SARS-CoV-2 Hongwei Gao, Renhui Dai, Ruiling Su
5 [GO] 2023―Jan―11 SARS-CoV-2 E protein: pathogenesis and potential therapeutic development Shilin Zhou, Panpan Lv, Mingxue Li, Zihui Chen, Hong Xin, Svetlana Reilly, Xuemei Zhang
6 [GO] 2023―Jan―02 From Immunogen to COVID-19 vaccines: Prospects for the post-pandemic era Ganggang Miao, Zhiqiang Chen, Hengsong Cao, Wenhao Wu, Xi Chu, Hanyuan Liu, et al. (+7)
7 [GO] 2022―Dec―16 The influence of the COVID-19 pandemic on the prescription of multiple sclerosis medication in Germany Jonathan Orschiedt, Elizabeth Jacyshyn-Owen, Maria Kahn, Sven Jansen, Natalie Joschko, Markus Eberl, et al. (+3)
8 [GO] 2022―Dec―09 Humulus lupus extract rich in xanthohumol improves the clinical course in critically ill COVID-19 patients Wojciech Dabrowski, Mariusz Gagos, Dorota Siwicka-Gieroba, Mariusz Piechota, Jan Siwiec, Magdalena Bielacz, et al. (+5)
9 [GO] 2022―Dec―05 A potential host and virus targeting tool against COVID-19: Chemical characterization, antiviral, cytoprotective, antioxidant, respiratory smooth muscle relaxant effects of Paulownia tomentosa Steud Fabio Magurano, Matteo Micucci, Domenico Nuzzo, Melissa Baggieri, Pasquale Picone, Silvia Gioacchini, et al. (+15)
10 [GO] 2022―Nov―07 Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions Ahmed I. Abulsoud, Hussein M. El-Husseiny, Ahmed A. El-Husseiny, Hesham A. El-Mahdy, Ahmed Ismail, Samy Y. Elkhawaga, et al. (+11)
11 [GO] 2022―Oct―31 Identification of phytochemicals in Qingfei Paidu decoction for the treatment of coronavirus disease 2019 by targeting the virus-host interactome Yuyun Li, Yan Wu, Siyan Li, Yibin Li, Xin Zhang, Zeren Shou, et al. (+8)
12 [GO] 2022―Oct―17 The role of SARS-CoV-2 accessory proteins in immune evasion Milad Zandi, Maryam Shafaati, Davood Kalantar-Neyestanaki, Hossein Pourghadamyari, Mona Fani, Saber Soltani, et al. (+2)
13 [GO] 2022―Oct―11 Highly pathogenic coronaviruses and the kidney Fang Wang, Xiao-Guo Suo, Cong Wang, Jia-Nan Wang, Xiao-Yan He, Fa-Cai Wang, et al. (+5)
14 [GO] 2022―Sep―28 Ganoderma microsporum immunomodulatory protein acts as a multifunctional broad-spectrum antiviral against SARS-CoV-2 by interfering virus binding to the host cells and spike-mediated cell fusion Ha Phan Thanh Ho, Di Ngoc Kha Vo, Tung-Yi Lin, Jo-Ning Hung, Ya-Hui Chiu, Ming-Han Tsai
15 [GO] 2022―Aug―31 The landscape of potential health benefits of carotenoids as natural supportive therapeutics in protecting against Coronavirus infection Louise W. Lu, Yao Gao, Siew-Young Quek, Meika Foster, Charles T. Eason, Min Liu, et al. (+3)
16 [GO] 2022―Aug―30 Genome-wide transcriptional profiling of pulmonary functional sequelae in ARDS- secondary to SARS-CoV-2 infection María C. García-Hidalgo, Rafael Peláez, Jessica González, Sally Santisteve, Iván D. Benítez, Marta Molinero, et al. (+24)
17 [GO] 2022―Aug―22 The favorable impacts of silibinin polyphenols as adjunctive therapy in reducing the complications of COVID-19: A review of research evidence and underlying mechanisms Vali Musazadeh, Arash Karimi, Nasim bagheri, Jaber Jafarzadeh, Sarvin Sanaei, Mahdi Vajdi, et al. (+2)
18 [GO] 2022―Aug―17 Cerebral microvascular complications associated with SARS-CoV-2 infection: How did it occur and how should it be treated? Neda Omidian, Pantea Mohammadi, Mona Sadeghalvad, Hamid-Reza Mohammadi-Motlagh
19 [GO] 2022―Aug―17 COVID-19-associated Liver Injury: Clinical Characteristics, Pathophysiological Mechanisms and Treatment Management Penghui Li, Ying Liu, Ziqi Cheng, Xiaorui Yu, Yinxiong Li
20 [GO] 2022―Aug―15 Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2? Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, Fahad A. Alhumaydhi, Talha Bin Emran, Polrat Wilairatana
21 [GO] 2022―Aug―12 Recent advances in point of care testing for COVID-19 detection Renata Salgado Fernandes, Juliana de Oliveira Silva, Karina Braga Gomes, Ricardo Bentes Azevedo, Danyelle M Townsend, Adriano de Paula Sabino, Andre Luis Branco de Barros
22 [GO] 2022―Aug―02 A comprehensive insight into current control of COVID-19: Immunogenicity, vaccination, and treatment. Yasser Mohamed, Yousra A. El-Maradny, Ahmed K. Saleh, AbdElAziz A. Nayl, Hamada El-Gendi, Esmail M. El-Fakharany
23 [GO] 2022―Jul―21 Early reduction of estimated Glomerular Filtration Rate (eGFR) predicts poor outcome in acutely ill hospitalized COVID-19 patients firstly admitted to medical regular wards (eGFR-COV19 study). Francesco Cei, Ludia Chiarugi, Simona Brancati, Maria Silvia Montini, Silvia Dolenti, Daniele Di Stefano, et al. (+14)
24 [GO] 2022―Jul―18 Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses Paul Andrei Negru, Denisa Claudia Miculas, Tapan Behl, Alexa Florina Bungau, Ruxandra-Cristina Marin, Simona Gabriela Bungau
25 [GO] 2022―Jul―18 Study on the potential of Sanghuangporus sanghuang and its components as COVID-19 spike protein receptor binding domain inhibitors Liang-Hsuan Chien, Jeng-Shyan Deng, Wen-Ping Jiang, Chin-Chu Chen, Ya-Ni Chou, Jaung-Geng Lin, Guan-Jhong Huang
26 [GO] 2022―Jul―11 Epigenetic activation of antiviral sensors and effectors of interferon response pathways during SARS-CoV-2 infection Jan Bińkowski, Olga Taryma-Leśniak, Karolina Łuczkowska, Anna Niedzwiedź, Kacper Lechowicz, Dominik Strapagiel, et al. (+8)
27 [GO] 2022―Jun―30 Molecular mechanisms involved in pathogenicity of SARS-CoV-2: Immune evasion and implications for therapeutic strategies Hatixhe Latifi-Pupovci
28 [GO] 2022―Jun―28 A comprehensive review of artificial intelligence and network based approaches to drug repurposing in Covid-19 Faheem Ahmed, Afaque Manzoor Soomro, Abdul Rahim Chethikkattuveli Salih, Anupama Samantasinghar, Arun Asif, In Suk Kang, Kyung Hyun Choi
29 [GO] 2022―Jun―02 Treatment with metformin glycinate reduces SARS-CoV-2 viral load: an in vitro model and randomized, double-blind, Phase IIb clinical trial Claudia Ventura-López, Karla Cervantes-Luevano, Janet S. Aguirre-Sánchez, Juan C. Flores-Caballero, Carolina Alvarez-Delgado, Johanna Bernaldez-Sarabia, et al. (+8)
30 [GO] 2022―May―30 SOLVx therapeutics vaccine - Activate T-cell immunity using broad surveillance epitope strategy against mutant strains SARS-COV2 Md Shamsuddin Sultan Khan, John A. Catanzaro
31 [GO] 2022―May―27 Plasmatic renin-angiotensin system in normotensive and hypertensive patients hospitalized with COVID-19 Mauro G. Silva, Gerardo R. Corradi, Juan I. Pérez Duhalde, Myriam Nuñez, Eliana M. Cela, Daniel H. Gonzales Maglio, et al. (+4)
32 [GO] 2022―May―24 Reviving the mutual impact of SARS-COV-2 and obesity on patients: From morbidity to mortality Tapan Behl, Sachin Kumar, Sukhbir Singh, Saurabh Bhatia, Ali Albarrati, Mohammed Albratty, et al. (+3)
33 [GO] 2022―May―24 Self-derived peptides from the SARS-CoV-2 spike glycoprotein disrupting shaping and stability of the homotrimer unit Monikaben Padariya, Alison Daniels, Christine Tait-Burkard, Ted Hupp, Umesh Kalathiya
34 [GO] 2022―May―16 High-throughput drug screening allowed identification of entry inhibitors specifically targeting different routes of SARS-CoV-2 Delta and Omicron Maria Kuzikov, Jannis Woens, Andrea Zaliani, Julia Hambach, Thomas Eden, Boris Fehse, et al. (+2)
35 [GO] 2022―May―16 Immune-based therapeutic approaches in COVID-19 Aysan Moeinafshar, Niloufar Yazdanpanah, Nima Rezaei
36 [GO] 2022―May―08 COVID-19 and Diabetes: Association Intensify Risk Factors for Morbidity and Mortality Prateek Sharma, Tapan Behl, Neelam Sharma, Sukhbir Singh, Ajmer Singh Grewal, Ali Albarrati, et al. (+3)
37 [GO] 2022―May―02 Molnupiravir combined with different repurposed drugs further inhibits SARS-CoV-2 infection in human nasal epithelium in vitro Hulda R. Jonsdottir, Denise Siegrist, Thomas Julien, Blandine Padey, Mendy Bouveret, Olivier Terrier, et al. (+8)
38 [GO] 2022―Apr―26 Seroprevalence of SARS-CoV-2-specific antibodies and vaccination-related adverse events in systemic lupus erythematosus and rheumatoid arthritis Peng Wang, Jing Ni, Ya-Ya Chu, Qing-Qing Chen, Guo-Cui Wu, Yang Fang, et al. (+9)
39 [GO] 2022―Apr―25 Ursodeoxycholic acid ameliorates cell migration retarded by the SARS-CoV-2 spike protein in BEAS-2B human bronchial epithelial cells Pham Xuan Thuy, Tran Duc Duy Bao, Eun-Yi Moon
40 [GO] 2022―Apr―15 Adamalysins in COVID-19 - Potential Mechanisms Behind Exacerbating the Disease Ivo Ricardo de Seabra Rodrigues Dias, Zhijian Cao, Hang Fai Kwok
41 [GO] 2022―Apr―14 Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D Montserrat Torres, Guiomar Casado, Lorena Vigón, Sara Rodríguez-Mora, Elena Mateos, Fernando Ramos-Martín, et al. (+45)
42 [GO] 2022―Apr―01 Advanced cell therapy with low tissue factor loaded product NestaCell® does not confer thrombogenic risk for critically ill COVID-19 heparin-treated patients Rodrigo Pinheiro Araldi, Benedito Carlos Prezoto, Vivian Gonzaga, Bruna Policiquio, Thais Biude Mendes, Fernanda D’Amélio, et al. (+5)
43 [GO] 2022―Mar―25 Lithium salts as a treatment for COVID-19: pre-clinical outcomes O Soriano-Torres, E Noa Romero, NL González Sosa, JM Enríquez Puertas, A Fragas Quintero, M García Montero, et al. (+18)
44 [GO] 2022―Mar―21 Epidemiology, clinical ramifications, and cellular pathogenesis of COVID-19 mRNA-vaccination-induced adverse cardiovascular outcomes: A state-of-the-heart review Talal Almas, Sarah Rehman, Eyad Mansour, Tarek Khedro, Ali Alansari, Jahanzeb Malik, et al. (+17)
45 [GO] 2022―Mar―09 Potential inhibitor for blocking binding between ACE2 and SARS-CoV-2 spike protein with mutations Ming-Shao Tsai, Wei-Tai Shih, Yao-Hsu Yang, Yu-Shih Lin, Geng-He Chang, Cheng-Ming Hsu, et al. (+8)
46 [GO] 2022―Mar―08 Traditional Chinese medicine against COVID-19: Role of the gut microbiota Zhihua Yang, Yangxi Liu, Lin Wang, Shanshan Lin, Xiangdong Dai, Haifeng Yan, et al. (+5)
47 [GO] 2022―Feb―28 The potential role of resveratrol as supportive antiviral in treating conditions such as COVID-19 - A formulator’s perspective Roy van Brummelen, Anna C. van Brummelen
48 [GO] 2022―Feb―25 Ex-vivo Mucolytic and Anti-inflammatory Activity of BromAc in Tracheal Aspirates From COVID-19 Jordana Grazziela A. Coelho dos Reis, Geovane Marques Ferreira, Alice Aparecida Lourenço, A.Ágata Lopes Ribeiro, Camila Pacheco da Silveira Martins da Mata, Patrícia de Melo Oliveira, et al. (+33)
49 [GO] 2022―Feb―17 Efficacy of a multiple-indication antiviral herbal drug (Saliravira®) for COVID-19 outpatients: A pre-clinical and randomized clinical trial study Reza Ramazani Khorshiddoust, Saleh Ramazani Khorshiddoust, Tahereh Hosseinabadi, Faezeh Mottaghitalab, Farzad Mokhtari, Fatemeh Azadinia, et al. (+33)
50 [GO] 2022―Feb―14 Role of the renin-angiotensin system in NETosis in the coronavirus disease 2019 (COVID-19) Qingguang Zhang, Shang Ling, Kaili Hu, Jun Liu, Jin-Wen Xu
51 [GO] 2022―Feb―04 Therapeutic dilemmas in addressing SARS-CoV-2 infection: Favipiravir versus Remdesivir Paul Andrei Negru, Andrei-Flavius Radu, Cosmin Mihai Vesa, Tapan Behl, Mohamed M. Abdel-Daim, Aurelia Cristina Nechifor, et al. (+5)
52 [GO] 2022―Jan―20 Natural products can be used in therapeutic management of COVID-19: Probable mechanistic insights Sabeeha Ali, Manzar Alam, Fatima Khatoon, Urooj Fatima, Abdelbaset Mohamed Elasbali, Mohd Adnan, et al. (+4)
53 [GO] 2022―Jan―19 Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine Thuy Trang Nguyen, Trang Ho Thu Quach, Thanh Mai Tran, Huynh Ngoc Phuoc, Ha Thi Nguyen, Tuong Kha Vo, Giau Van Vo
54 [GO] 2022―Jan―04 Targeting chronic COVID-19 lung injury; Tofacitinib can be used against tissue-resident memory T cells Sepideh Zununi Vahed, Seyed Mahdi Hosseiniyan Khatibi, Elham Ahmadian, Mohammadreza Ardalan
55 [GO] 2021―Dec―28 Mortality risk and antibiotic use for COVID-19 in hospitalized patients over 80 Andreea Rosca, Thibaut Balcaen, Audrey Michaud, Jean-Philippe Lanoix, Julien Moyet, Ingrid Marcq, et al. (+3)
56 [GO] 2021―Dec―25 Pulmonary Artery Targeted Therapy in Treatment of COVID-19 Related ARDS. Literature Review Oskar Puk, Aleksandra Nowacka, Klaudia Smulewicz, Katarzyna Mocna, Wiktor Bursiewicz, Natalia Kęsy, et al. (+2)
57 [GO] 2021―Dec―22 Impact of early interferon-β treatment on the prognosis of patients with COVID-19 in the first wave: A post hoc analysis from a multicenter cohort Sonsoles Salto-Alejandre, Zaira R. Palacios-Baena, José Ramón Arribas, Juan Berenguer, Jordi Carratalà, Inmaculada Jarrín, et al. (+4)
58 [GO] 2021―Dec―15 A critical analysis of the SARS-CoV-2 (COVID-19) pandemic, emerging variants, therapeutic interventions, and vaccination strategies Chang-Xing Li, Sobia Noreen, Li-Xue Zhang, Muhammad Saeed, Pei-Feng Wu, Muhammad Ijaz, et al. (+6)
59 [GO] 2021―Dec―10 Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines Mohammad Reza Zinatizadeh, Peyman Kheirandish Zarandi, Maryam Zinatizadeh, Mohammad Hadi Yousefi, Jaffar Amani, Nima Rezaei
60 [GO] 2021―Dec―09 RdRp inhibitors and COVID-19: Is molnupiravir a good option? Seyed Mohammad Reza Hashemian, Mohammad Hossein Pourhanifeh, Michael R. Hamblin, Mohammad Karim Shahrzad, Hamed Mirzaei
61 [GO] 2021―Dec―09 Interaction of SARS-CoV-2 with cardiomyocytes: insight into the underlying molecular mechanisms of cardiac injury and pharmacotherapy Abdulhamid Abdi, Shahad AlOtaiby, Firas Al Badarin, Ali Khraibi, Hamdan Hamdan, Moni Nader
62 [GO] 2021―Dec―07 Plant lectins as prospective antiviral biomolecules in the search for COVID-19 eradication strategies Md. Nasir Ahmed, Rownak Jahan, Veeranoot Nissapatorn, Polrat Wilairatana, Mohammed Rahmatullah
63 [GO] 2021―Nov―12 Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets Masoumeh Farahani, Zahra Niknam, Leila Mohammadi Amirabad, Nasrin Amiri-Dashatan, Mehdi Koushki, Mohadeseh Nemati, et al. (+4)
64 [GO] 2021―Nov―12 Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications Jamal Majidpoor, Keywan Mortezaee
65 [GO] 2021―Oct―28 Chemically Modified mRNA Beyond COVID-19: Potential Preventive and Therapeutic Applications for Targeting Chronic Diseases Dana Elkhalifa, Menatallah Rayan, Ahmed T. Negmeldin, Abdelbary Elhissi, Ashraf Khalil
66 [GO] 2021―Oct―22 A comprehensive review on efficient approaches for combating coronaviruses Mahdi Pouresmaieli, Elena Ekrami, Ali Akbari, Negin Noorbakhsh, Negin Borzooee Moghadam, Matin Mamoudifard
67 [GO] 2021―Oct―16 Role of Myeloid-derived suppressor cells in viral respiratory infections; Hints for Discovering Therapeutic Targets for COVID-19 Khadijeh Koushki, Maryam Salemi, Seyed Mohammad Miri, Yaser Arjeini, Mohsen Keshavarz, Amir Ghaemi
68 [GO] 2021―Oct―07 Metformin to decrease COVID-19 severity and mortality: Molecular mechanisms and therapeutic potential Olexandr Kamyshnyi, Victoriya Matskevych, Tetyana Lenchuk, Olha Strilbytska, Kenneth Storey, Oleh Lushchak
69 [GO] 2021―Oct―02 Sterilizing Immunity against COVID-19: Developing effective Helper T cells I and II activating vaccines Isaac Kyei-Barffour, Samuel Addo Akwetey, Enoch Aninagyei, George Ghartey-Kwansah, Desmond Omane Acheampong
70 [GO] 2021―Oct―02 Clinical drug therapies and biologicals currently used or in clinical trial to treat COVID-19 Rory J. Malek, Colin A. Bill, Charlotte M. Vines
71 [GO] 2021―Sep―27 Beneficial Effects of novel Aureobasidium Pullulans strains produced Beta-1,3-1,6 Glucans on Interleukin-6 and D-Dimer levels in COVID-19 patients; results of a randomized multiple-arm pilot clinical study Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya, Vaddi Suryaprakash, Kosagi-Sharaf Rao, Nobunao Ikewaki, Tohru Sonoda, et al. (+5)
72 [GO] 2021―Sep―27 Role of microRNAs in COVID-19 with implications for therapeutics Nahid Arghiani, Tracy Nissan, Maryam M. Matin
73 [GO] 2021―Sep―22 A Digital Health Platform for Assisting the Diagnosis and Monitoring of COVID-19 Progression: An Adjuvant Approach for Augmenting the Antiviral Response and Mitigating the Immune-mediated Target Organ Damage Yuval Ishay, Assaf Potruch, Asaf Schwartz, Marc Berg, Khurram Jamil, Samuel Agus, Yaron Ilan
74 [GO] 2021―Sep―21 Cinnamon and its possible impact on COVID-19: The viewpoint of traditional and conventional medicine Maryam Yakhchali, Zahra Taghipour, Mehran Mirabzadeh Ardakani, Mahdi Alizadeh Vaghasloo, Mahdi Vazirian, Sima Sadrai
75 [GO] 2021―Sep―15 Arginine vasopressin and pathophysiology of COVID-19: An innovative perspective Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Safaa Qusti, Eida M. Alshammari, Francis O. Atanu, Gaber El-Saber Batiha
76 [GO] 2021―Sep―13 Neurokinin-1 Receptor as a potential drug target for COVID-19 treatment Riffat Mehboob
77 [GO] 2021―Sep―11 SARS-CoV-2 New Variants: Characteristic Features and impact on the Efficacy of Different Vaccines Abbas Khan, Taimoor Khan, Shughla Ali, Summiya Aftab, Yanjing Wang, Wang Qiankun, et al. (+7)
78 [GO] 2021―Sep―09 Nanoparticles as an Effective Drug Delivery System in Covid-19 Neehasri Kumar Chowdhuryz, Reshma Choudhury, Gaurav Ambadas Sonawane, Shankar Mavinamar, Xiaoming Lyu, Ramendra Pati Pandey, Chung-Ming Chang
79 [GO] 2021―Sep―02 Potential of herbal products in prevention and treatment of COVID-19. Literature review Aleksander Gajewski, Anna Kośmider, Aleksandra Nowacka, Oskar Puk, Michał Wiciński
80 [GO] 2021―Aug―30 Factors regulating dynamics of angiotensin-converting enzyme-2 (ACE2), the gateway of SARS-CoV-2: Epigenetic modifications and therapeutic interventions by epidrugs Suvasmita Rath, Venkateswarlu Perikala, Atala Bihari Jena, Jagneshwar Dandapat
81 [GO] 2021―Aug―27 Recent Advances in Management of COVID-19: A review Soraya Mouffak, Qamar Shubbar, Ekram Saleh, Raafat El-Awady
82 [GO] 2021―Aug―20 MMP-2 and MMP-9 levels in plasma are altered and associated with mortality in COVID-19 patients Carolina D`Avila-Mesquita, Ariel E.S. Couto, Ligia C.B. Campos, Tauana F. Vasconcelos, Jessyca M. Barbosa, Carlos A.C. Corsi, et al. (+16)
83 [GO] 2021―Aug―10 Repurposing methylene blue in the management of COVID-19: mechanistic aspects and clinical investigations Neha Dabholkar, Srividya Gorantla, Sunil Kumar Dubey, Amit Alexander, Rajeev Taliyan, Gautam Singhvi
84 [GO] 2021―Aug―05 COVID-19 challenges and its therapeutics Sabi Ur Rehman, Shaheed Ur Rehman, Hye Hyun Yoo
85 [GO] 2021―Aug―05 GB-2 Blocking the Interaction between ACE2 and Wild Type and Mutation of Spike Protein of SARS-CoV-2 Ming-Shao Tsai, Yao-Hsu Yang, Yu-Shih Lin, Geng-He Chang, Cheng-Ming Hsu, Reming-Albert Yeh, et al. (+7)
86 [GO] 2021―Jul―29 Interleukin-17A (IL-17A): a silent amplifier of COVID-19 Francesco Maione, Gian Marco Casillo, Federica Raucci, Cristian Salvatore, Giovanna Ambrosini, Luisa Costa, et al. (+3)
87 [GO] 2021―Jul―28 In silico drug repurposing in COVID-19: a network-based analysis Pasquale Sibilio, Simone Bini, Giulia Fiscon, Marialuisa Sponziello, Federica Conte, Valeria Pecce, et al. (+6)
88 [GO] 2021―Jul―28 Potential protective role of the anti-PD-1 blockade against SARS-CoV-2 infection Annoor Awadasseid, Qiang Yin, Yanling Wu, Wen Zhang
89 [GO] 2021―Jul―27 Kidney injury in COVID-19 patients, drug development and their renal complications: Review study Zeynab Mohamadi Yarijani, Houshang Najafi
90 [GO] 2021―Jul―27 A secondary approach with conventional medicines and supplements to recuperate current COVID-19 status Apu Chowdhury, Muhammad Sajid, Nabila Jahan, Temitope Isaac Adelusi, Pulak Maitra, Guolian Yin, et al. (+3)
91 [GO] 2021―Jul―23 Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2 Javier T. Granados-Riveron, Guillermo Aquino-Jarquin
92 [GO] 2021―Jul―14 Lecithinized superoxide dismutase in the past and in the present: Any role in the actual pandemia of COVID-19? Ilaria Farella, Raffaella Panza, Manuela Capozza, Nicola Laforgia
93 [GO] 2021―Jun―10 Role of toll-like receptor 7/8 pathways in regulation of interferon response and inflammatory mediators during SARS-CoV2 infection and potential therapeutic options Shetty Ravi Dyavar, Rahul Singh, Rohini Emani, Ganesh P. Pawar, Vinod D. Chaudhari, Anthony T. Podany, et al. (+3)
94 [GO] 2021―Jun―05 Identification of oligopeptides from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) non structural protein 8 (NSP8) and their similarities with type 1 angiotensin II receptor key sites Ammar Achour
95 [GO] 2021―May―28 Therapeutic use of specific tumour necrosis factor inhibitors in inflammatory diseases including COVID-19 Serena Patel, Meenu Wadhwa
96 [GO] 2021―May―27 CRISPR is a useful biological tool for detecting nucleic acid of SARS-CoV-2 in human clinical samples Md. Rashidur Rahman, Md. Amjad Hossain, Md. Mozibullah, Fateh Al Mujib, Afrina Afrose, Md. Shahed-Al-Mahmud, Md. Aminul Islam Apu
97 [GO] 2021―May―24 Theobroma cacao L. compounds: Theoretical study and molecular modeling as inhibitors of main SARS-CoV-2 protease Osvaldo Yañez, Manuel Isaías Osorio, Carlos Areche, Alejandro Vasquez-Espinal, Jessica Bravo, Angélica Sandoval-Aldana, et al. (+6)
98 [GO] 2021―May―18 Main Protease Inhibitors and Drug Surface Hotspots for the Treatment of COVID-19: A Drug Repurposing and Molecular Docking Approach Mahmudul Hasan, Md. Sorwer Alam Parvez, Kazi Faizul Azim, Md. Abdus Shukur Imran, Topu Raihan, Airin Gulshan, et al. (+4)
99 [GO] 2021―May―15 Corrigendum to: “Novel and emerging mutations of SARS-CoV-2: Biomedical implications” [Biomed. Pharmacother. 139 (2021) 111599] Elmira Mohammadi, Fatemeh Shafiee, Kiana Shahzamani, Mohammad Mehdi Ranjbar, Abbas Alibakhshi, Shahrzad Ahangarzadeh, et al. (+5)
100 [GO] 2021―May―06 COVID-19 and Metabolic Comorbidities: An Update on Emerging Evidences for Optimal Therapies Shuang Hua, Yong Yang, Danqi Zou, Jufei Li, Kaixuan Yan, Ying Xu, et al. (+3)
101 [GO] 2021―Apr―27 Disease-drug and drug-drug interaction in COVID-19: risk and assessment Devendra Kumar, Neerja Trivedi
102 [GO] 2021―Apr―23 Novel and emerging mutations of SARS-CoV-2: Biomedical implications Elmira Mohammadi, Fatemeh Shafiee, Kiana Shahzamani, Mohammad Mehdi Ranjbar, Abbas Alibakhshi, Shahrzad Ahangarzadeh, et al. (+5)
103 [GO] 2021―Apr―21 Resveratrol-zinc nanoparticles or pterostilbene-zinc: Potential COVID-19 mono and adjuvant therapy Mina T. Kelleni
104 [GO] 2021―Apr―08 Babaodan controls excessive immune responses and may represent a cytokine-targeted agent suitable for COVID-19 treatment Jing Qian, Hangdi Xu, Dongqing Lv, Wei Liu, Enguo Chen, Yong Zhou, et al. (+3)
105 [GO] 2021―Apr―06 Angiotensin II: A possible target for therapeutic intervention in COVID-19 Mohammad Rafi Khezri, Keyvan Yousefi, Morteza Ghasemnejad-Berenji
106 [GO] 2021―Apr―06 WILL CURCUMIN NANOSYSTEMS BE THE NEXT PROMISING ANTIVIRAL ALTERNATIVES IN COVID-19 TREATMENT TRIALS? Douglas Dourado, Danielle T. Freire, Daniel T. Pereira, Lucas Amaral-Machado, Éverton N. Alencar, André Luis Branco de Barros, E. Sócrates T. Egito
107 [GO] 2021―Apr―01 Identification of FDA Approved Drugs Against SARS-CoV-2 RNA Dependent RNA Polymerase (RdRp) and 3-chymotrypsin-like Protease (3CLpro), Drug Repurposing Approach Zahra Molavi, Sara Razi, Seyed Amir Mirmotalebisohi, Amirjafar Adibi, Marzieh Sameni, Farshid Karami, et al. (+10)
108 [GO] 2021―Mar―20 Efficacy of Brazilian Green Propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: a randomized, controlled clinical trial Marcelo Augusto Duarte Silveira, David De Jong, Andresa Aparecida Berretta, Erica Batista dos Santos Galvão, Juliana Caldas Ribeiro, Thiago Cerqueira-Silva, et al. (+19)
109 [GO] 2021―Mar―18 Potential Therapeutic Agents to COVID-19: An Update Review on Antiviral Therapy, Immunotherapy, and Cell Therapy Mona Sadat Mirtaleb, Amir Hossein Mirtaleb, Hassan Nosrati, Jalal Heshmatnia, Reza Falak, Reza Zolfaghari Emameh
110 [GO] 2021―Mar―18 Impact of renin-angiotensin system inhibitors on mortality during the COVID Pandemic among STEMI patients undergoing mechanical reperfusion: Insight from an international STEMI registry Giuseppe De Luca, Miha Cercek, Lisette Okkels Jensen, Oliver Bushljetikj, Lucian Calmac, Tom Johnson, et al. (+61)
111 [GO] 2021―Mar―06 Antiviral activity of oleandrin and a defined extract of Nerium oleander against SARS-CoV-2 Kenneth S. Plante, Varun Dwivedi, Jessica A. Plante, Diana Fernandez, Divya Mirchandani, Nathen Bopp, et al. (+11)
112 [GO] 2021―Feb―26 Flavonoids against the SARS-CoV-2 induced inflammatory storm Alena Liskova, Marek Samec, Lenka Koklesova, Samson M. Samuel, Kevin Zhai, Raghad Khalid AL-Ishaq, et al. (+17)
113 [GO] 2021―Feb―25 Fluoxetine as an Anti-Inflammatory Therapy in SARS-CoV-2 Infection Justin Fortune Creeden, Ali Sajid Imami, Hunter M. Eby, Cassidy Gillman, Kathryn N. Becker, Jim Reigle, et al. (+5)
114 [GO] 2021―Feb―15 Heme oxygenase-1 inducer hemin does not inhibit SARS-CoV-2 virus infection Sheila Maestro, Karol M. Córdoba, Cristina Olague, Josepmaria Argemi, Matías A. Ávila, Gloria González-Aseguinolaza, et al. (+2)
115 [GO] 2021―Feb―06 Induced dysregulation of ACE2 by SARS-CoV-2 plays a key role in COVID-19 severity Maryam Eskandari Mehrabadi, Roohullah Hemmati, Amin Tashakor, Ahmad Homaei, Masoumeh Yousefzadeh, Karim Hemati, Saman Hosseinkhani
116 [GO] 2021―Feb―05 Research Progress of Traditional Chinese Medicine Against COVID-19 Wei Ren, Pan Liang, Yue Ma, Qin Sun, Qingrong Pu, Li Dong, et al. (+5)
117 [GO] 2021―Feb―05 An update review of emerging small-molecule therapeutic options for COVID-19 Dengke Tian, Yuzhi Liu, Chengyuan Liang, Liang Xin, Xiaolin Xie, Dezhu Zhang, et al. (+5)
118 [GO] 2021―Feb―05 Repurposing potential of Ayurvedic medicinal plants derived active principles against SARS-CoV-2 associated target proteins revealed by molecular docking, molecular dynamics and MM-PBSA studies Akalesh Kumar Verma, Vikas Kumar, Sweta Singh, Bhabesh Ch. Goswami, Ihosvany Camps, Aishwarya Sekar, et al. (+2)
119 [GO] 2021―Feb―03 SARS-CoV-2: From the pathogenesis to potential anti-viral treatments Peyman Kheirandish Zarandi, Mohammad Reza Zinatizadeh, Maryam Zinatizadeh, Mohammad Hadi Yousefi, Nima Rezaei
120 [GO] 2021―Jan―28 Stem cell therapy in COVID-19: Pooled evidence from SARS-CoV-2, SARS-CoV, MERS-CoV and ARDS: A systematic review Saniya Mahendiratta, Seema Bansal, Phulen Sarma, Harish Kumar, Gajendra Choudhary, Subodh Kumar, et al. (+3)
121 [GO] 2021―Jan―28 Targets and strategies for vaccine development against SARS-CoV-2 Jonaid Ahmad Malik, Almas Hanif Mulla, Tahmeena Farooqi, Faheem Hyder Pottoo, Sirajudheen Anwar, Kannan R.R. Rengasamy
122 [GO] 2021―Jan―28 Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines Annoor Awadasseid, Yanling Wu, Yoshimasa Tanaka, Wen Zhang
123 [GO] 2021―Jan―15 The Direct Evidence and Mechanism of Traditional Chinese Medicine Treatment of COVID-19 Xuedong An, YueHong Zhang, Liyun Duan, De Jin, Shenghui Zhao, RongRong Zhou, et al. (+3)
124 [GO] 2021―Jan―14 The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators Hosam M. Habib, Sahar Ibrahim, Aamnah Zaim, Wissam H. Ibrahim
125 [GO] 2021―Jan―14 Human endeavor for anti-SARS-CoV-2 pharmacotherapy: a major strategy to fight the pandemic Ruixuan Wang, Preyesh Stephen, Yi Tao, Wenfa Zhang, Sheng-Xiang Lin
126 [GO] 2021―Jan―13 Impact of virus genetic variability and host immunity for the success of COVID-19 vaccines Wagner Gouvêa dos Santos
127 [GO] 2021―Jan―08 COVID-19 and inflammatory bowel disease: a pathophysiological assessment Chunxiu Yang, Shu-Yuan Xiao
128 [GO] 2021―Jan―08 Multifunctional Angiotensin Converting Enzyme 2, the SARS-CoV-2 Entry Receptor and Critical Appraisal of its Role in Acute Lung Injury Murat Oz, Dietrich Ernst Lorke
129 [GO] 2021―Jan―01 The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatment Esmé Jansen van Vuren, Stephan F. Steyn, Christiaan B. Brink, Marisa Möller, Francois P. Viljoen, Brian H. Harvey
130 [GO] 2020―Dec―17 4-Aminoquinoline Compounds from the Spanish Flu to COVID-19 Roberto Barbosa Bazotte, Sandro Massao Hirabara, Tamires Afonso Duarte Serdan, Raquel Bragante Gritte, Talita Souza-Siqueira, Renata Gorjao, et al. (+5)
131 [GO] 2020―Dec―17 Could natural products modulate early inflammatory responses, preventing Acute Respiratory Distress Syndrome in COVID-19-confirmed patients? Lucas Amaral-Machado, Wógenes N. Oliveira, Victor M. Rodrigues, Nathan A. Albuquerque, Éverton N. Alencar, Eryvaldo S.T. Egito
132 [GO] 2020―Nov―28 Potential Effects of SARS-CoV-2 on the Gastrointestinal Tract and Liver Han-Yu Lei, Ying-He Ding, Kai Nie, Yin-Miao Dong, Jia-Hao Xu, Meng-Ling Yang, et al. (+6)
133 [GO] 2020―Nov―20 A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: a bedside-to-bench study Keng-Chang Tsai, Yi-Chia Huang, Chia-Ching Liaw, Chia-I Tsai, Chun-Tang Chiou, Chien-Jung Lin, et al. (+13)
134 [GO] 2020―Nov―17 Potential molecular targets of nonstructural proteins for the development of antiviral drugs against SARS-CoV-2 infection Xiao-huan Liu, Xiao Zhang, Zhen-hua Lu, You Shuang Zhu, Tao Wang
135 [GO] 2020―Nov―11 Prevention and treatment of COVID-19: focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine Bianza Moise Bakadia, Feng He, Tiatou Souho, Lallepak Lamboni, Muhammad Wajid Ullah, Biaou Ode Boni, et al. (+3)
136 [GO] 2020―Nov―11 SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role Ahmad Ud Din, Maryam Mazhar, Muhammad Wasim, Waqar Ahmad, Asma Bibi, Adil Hassan, et al. (+9)
137 [GO] 2020―Nov―05 Early use of Non-steroidal anti-inflammatory drugs in COVID-19 might reverse pathogenesis, prevent complications and improve clinical outcomes Mina T. Kelleni
138 [GO] 2020―Oct―23 Innate and adaptive immune responses against coronavirus Arezoo Hosseini, Vida Hashemi, Navid Shomali, Faezeh Asghari, Tohid Gharibi, Morteza Akbari, et al. (+2)
139 [GO] 2020―Oct―20 Targeting the SARS-CoV2 nucleocapsid protein for potential therapeutics using immuno-informatics and structure-based drug discovery techniques Alexander Kwarteng, Ebenezer Asiedu, Samuel Amoah Sakyi, Samuel Opoku Asiedu
140 [GO] 2020―Oct―19 Decoding the silent walk of COVID-19: Halting its spread using old bullets Mukesh Kumar, Jitender Madan, Rupinder Kaur Sodhi, Shashi Bala Singh, Anju Katyal
141 [GO] 2020―Oct―16 Potential of natural astaxanthin in alleviating the risk of cytokine storm in COVID-19 Jayanta Talukdar, Bhaskar Bhadra, Tomal Dattaroy, Vinod Nagle, Santanu Dasgupta
142 [GO] 2020―Sep―30 From the perspective of Traditional Chinese Medicine: treatment of mental disorders in COVID-19 survivors Ke Ma, Xin Wang, Shiyao Feng, Xia Xushan, Hongxiu Zhang, Abdul Rahaman, et al. (+8)
143 [GO] 2020―Sep―30 Tocilizumab combined with favipiravir in the treatment of COVID-19: A multicenter trial in a small sample size Hong Zhao, Qi Zhu, Chi Zhang, Jiawen Li, Ming Wei, Yuhong Qin, et al. (+6)
144 [GO] 2020―Sep―17 CRISPR/Cas13: A potential therapeutic option of COVID-19 Melika Lotfi, Nima Rezaei
145 [GO] 2020―Sep―09 Male Predisposition to Severe COVID-19: Review of Evidence and Potential Therapeutic Prospects Desmond Omane Acheampong, Isaac Kyei Barffour, Alex Boye, Enoch Aninagyei, Stephen Ocansey, Martin Tangnaa Morna
146 [GO] 2020―Aug―28 The role of Interleukin 6 inhibitors in therapy of severe COVID-19 E. Nasonov, M. Samsonov
147 [GO] 2020―Aug―27 Can a metabolism-targeted therapeutic intervention successfully subjugate coronavirus? A scientific rational Kamran Mansouri, Mohsen Rastegari-Pouyani, Maryam Ghanbri-Movahed, Mehrnoush Safarzadeh, Sara Kiani, Zahra Ghanbari-Movahed
148 [GO] 2020―Aug―24 ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19 Mengzhen Dong, Jie Zhang, Xuefeng Ma, Jie Tan, Lizhen Chen, Shousheng Liu, et al. (+2)
149 [GO] 2020―Aug―24 Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2 Katya Uzunova, Elena Filipova, Velichka Pavlova, Toni Vekov
150 [GO] 2020―Aug―20 Candesartan could ameliorate the COVID-19 cytokine storm Abdel G. Elkahloun, Juan M. Saavedra
151 [GO] 2020―Aug―19 Lianhua Qingwen prescription for Coronavirus disease 2019 (COVID-19) treatment: advances and prospects Liu-Cheng Li, Zhi-Hui Zhang, Wen-Cheng Zhou, Jie Chen, Hua-Qian Jin, Hong-Mei Fang, et al. (+4)
152 [GO] 2020―Aug―17 Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease Andresa Aparecida Berretta, Marcelo Augusto Duarte Silveira, José Manuel Cóndor Capcha, David De Jong
153 [GO] 2020―Aug―13 SARS-CoV-2 neutralizing antibody levels are correlated with severity of COVID-19 pneumonia Wei Chen, Jie Zhang, Xijian Qin, Weixiao Wang, Miaomiao Xu, Lin-Fa Wang, et al. (+9)
154 [GO] 2020―Aug―01 Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies Arif Hussain, Anwarul Hasan, Mohammad Mahdi Nejadi Babadaei, Samir Haj Bloukh, Muhammad E.H. Chowdhury, Majid Sharifi, et al. (+2)
155 [GO] 2020―Jul―30 Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19 Ulf Norinder, Astrud Tuck, Kalle Norgren, Vesna Munic Kos
156 [GO] 2020―Jul―28 Clinical efficacy of glucocorticoid on the treatment of patients with COVID-19 pneumonia: A single-center experience Yan Hu, Tingping Wang, Zhimin Hu, Xuan Wang, Zhengbin Zhang, Li Li, Peng Peng
157 [GO] 2020―Jul―28 SARS-CoV infection crosstalk with human host cell noncoding-RNA machinery: An in-silico approach Suresh K. Alahari, Hassan Yousefi, Arash Poursheikhani, Zahra bahmanpour, Mousa Vatanmakanian, Mohammad Taheri, Ladan Mashouri
158 [GO] 2020―Jul―17 PARP-inhibitors in a non-oncological indication as COVID-19: Are we aware about its potential role as anti-thrombotic drugs? The discussion is open Ettore Capoluongo
159 [GO] 2020―Jul―04 Clinical Retrospective Study on the Efficacy of Qingfei Paidu Decoction Combined with Western Medicine for COVID-19 Treatment Siyi Xin, Xueqi Cheng, Bo Zhu, Xiaolong Liao, Feng Yang, Lina Song, et al. (+13)
160 [GO] 2020―Jul―04 Outbreak of COVID-19: An emerging global pandemic threat Minhua Peng
161 [GO] 2020―Jul―03 Natural History of COVID-19 and Current Knowledge on Treatment Therapeutic Options Wagner Gouvea dos Santos
162 [GO] 2020―Jun―23 When science goes viral: The research response during three months of the COVID-19 outbreak Joanna Nowakowska, Joanna Sobocińska, Mateusz Lewicki, Żaneta Lemańska, Piotr Rzymski
163 [GO] 2020―Jun―19 STRATEGIES AND PERSPECTIVES TO DEVELOP SARS-CoV-2 DETECTION METHODS AND DIAGNOSTICS Rekha Jalandra, Amit K. Yadav, Damini Verma, Nishu Dalal, Minakshi Sharma, Rajeev Singh, et al. (+2)
164 [GO] 2020―Jun―19 Yidu-toxicity blocking lung decoction ameliorates inflammation in severe pneumonia of SARS-COV-2 patients with Yidu-toxicity blocking lung syndrome by eliminating IL-6 and TNF-a Jie Zhao, Xiaodong Yang, Chenghua Wang, Shuai Song, Kun Cao, Taohua Wei, et al. (+5)
165 [GO] 2020―May―30 Analysis of the molecular mechanism of Pudilan (PDL) treatment for COVID-19 by network pharmacology tools Qi Kong, Yue Wu, Yu Gu, Qi Lv, Feifei Qi, Shuran Gong, Xiuping Chen
166 [GO] 2020―May―25 Protection against COVID-19 injury by Qingfei Paidu decoction via anti-viral, anti-inflammatory activity and metabolic programming Jian Chen, Yong-kui Wang, Yuan Gao, Ling-San Hu, Jiang-wei Yang, Jian-ru Wang, et al. (+4)
167 [GO] 2020―May―14 Emerging pharmacotherapies for COVID-19 Rachana Salvi, Panini Patankar
168 [GO] 2020―May―13 Advances in the relationship between coronavirus infection and cardiovascular diseases Mengmeng Zhao, Menglong Wang, Jishou Zhang, Jing Ye, Yao Xu, Zhen Wang, et al. (+3)
169 [GO] 2020―Apr―28 New understanding of the damage of SARS-CoV-2 infection outside the respiratory system Yuhao Zhang, Xiuchao Geng, Yanli Tan, Qiang Li, Can Xu, Jianglong Xu, et al. (+5)
170 [GO] 2020―Apr―23 Occupational exposure to SARS-CoV-2 in burns treatment during the COVID-19 epidemic: Specific diagnosis and treatment protocol Zhifeng Huang, Donglin Zhuang, Bing Xiong, David Xingfei Deng, Hanhua Li, Wen Lai
 [1] 

170 Results       Page 1


[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.016 sec